
|Articles|July 5, 2013
- The Column-07-05-2013
- Volume 9
- Issue 12
How UHPLC and Large Molecules Fit Together
The use of UHPLC has triggered a remarkable increase in efficiency and throughput of LC and LC –MS methods. The fastest growing market segment in the pharmaceutical industry is biopharmaceuticals, with an increased interest in applying UHPLC to biopharmaceutical analysis.
Advertisement
The use of UHPLC has triggered a remarkable increase in efficiency and throughput of LC and LC–MS methods. The fastest growing market segment in the pharmaceutical industry is biopharmaceuticals, with an increased interest in applying UHPLC to biopharmaceutical analysis.
Articles in this issue
about 13 years ago
Market Profile: Supercritical Fluid Chromatography (SFC)about 13 years ago
Advances in cancer biomarker detection technologyabout 13 years ago
Melanoma nanosensorabout 13 years ago
Contributing Factors to Poor Resolution and Sample Recovery in UHPLCAdvertisement
Related to this article

Erin Chambers reflects on two leadership philosophies and a personal mantra that have shaped her approach to leading teams.

At ISC 2026, a tailored C4 stationary phase resolved over 30 of 64 possible siRNA diastereomers, aiding characterization of oligonucleotide conjugates.

At ISC 2026, a 20-minute IP-RPLC–UV assay distinguished mRNA capping variants without mass spectrometry, matching a UHPLC–MS reference method.

At ISC 2026, separation science advances included a MEMS gas chromatography column for space missions that raised measured efficiency by up to 74%
Advertisement
Advertisement
Trending on LCGC International
1
Sequential Surrogate Optimization for Supercritical Fluid Extraction–Supercritical Fluid Chromatography–Tandem Mass Spectrometry Method Development
2
"One-Shot" Solutions for Preparative Chiral Sub/Supercritical Fluid Chromatography Using Chiroptical Detection
3
UHPLC-MS Reveals Metabolic Signatures in Epilepsy
4
SFC Points to Greener Path for Chromatography
5
